Skip to Main Content

Dr. Deborah Dunsire is a biopharma lifer, rising to the upper ranks of Novartis before taking the helm of Millennium Pharmaceuticals right up until its $8.8 billion sale to Takeda. Now she’s back to lead a fledging upstart called XTuit Pharmaceuticals, a preclinical outfit crafting therapies for cancer and fibrotic disease.

Dunsire has also long been an advocate for gender diversity in biotech, and on this, International Women’s Day, we asked her how far the industry has come and how far it has to go.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!